MARCKSL1 protein expression was higher in ERα and PR negative tumors (p = 0.029 and p = 0.012, respectively), and tumors with high proliferation (MAI ≥10 (p = 0.004) or PPH3 ≥13 (p = 0.005)), but did not differ between categories of age ≥55, Nottingham grade, tumor size (≥2 cm), HER2, triple negative receptor status, Ki-67 ≥15 or ≥30. This evidence concerns the gene MARCKSL1 and neoplasm.